XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 4,702 $ 11,877,590 $ (16,890,626)   $ (5,008,334)
Beginning balance, shares at Dec. 31, 2019 4,701,552        
Stock-based compensation 992,549   992,549
Stock grant program vesting $ 20 (20)  
Stock grant program vesting, shares 20,278        
Clawback of stock granted $ (17) 17  
Claw back of stock granted, shares (16,667)        
Stock issued loan revisions $ 16 99,984   100,000
Stock issued loan revisions, shares 16,667        
Stock issuance related to debt $ 83 499,917   500,000
Stock issuance related to debt, shares 83,333        
Warrant issuance related to debt 76,822   76,822
Net income (loss) (3,265,601)   (3,265,601)
Ending balance, value at Jun. 30, 2020 $ 4,805 13,546,858 (20,156,227)   (6,604,564)
Ending balance, shares at Jun. 30, 2020 4,805,163        
Beginning balance, value at Mar. 31, 2020 $ 4,785 12,986,974 (18,586,257)   (5,594,498)
Beginning balance, shares at Mar. 31, 2020 4,784,885        
Stock-based compensation 559,904   559,904
Stock grant program vesting $ 20 (20)  
Stock grant program vesting, shares 20,278        
Net income (loss) (1,569,970)   (1,569,970)
Ending balance, value at Jun. 30, 2020 $ 4,805 13,546,858 (20,156,227)   (6,604,564)
Ending balance, shares at Jun. 30, 2020 4,805,163        
Beginning balance, value at Dec. 31, 2020 $ 4,719 14,553,438 (21,964,321) (7,406,164)
Beginning balance, shares at Dec. 31, 2020 4,718,714        
Stock-based compensation 590,407 590,407
Stock grant program vesting $ 17 (17)
Stock grant program vesting, shares 16,586        
Beneficial conversion feature 636,075 636,075
Conversion of Bridge Financing $ 254 1,907,971 1,908,225
Conversion of Bridge Financing, shares 254,425        
Stock issued with exercise of warrants $ 18 9,978 9,996
Stock issued with exercise of warrants,shares 18,412        
Stock issuance related to offering, net of offering costs of $4,596,257 $ 6,210 57,497,533 57,503,743
Stock issuance related to offering, net, of offering costs of $4,400,683 shares 6,210,000        
Common stock repurchased (3,474,270) (3,474,270)
Stock Options Exercised $ 5 32,390 $ 32,395
Stock Option Exercised, shares 4,777       4,777
Net income (loss) (331,138) $ (331,138)
Ending balance, value at Jun. 30, 2021 $ 11,223 75,227,775 (22,295,459) (3,474,270) 49,469,269
Ending balance, shares at Jun. 30, 2021 11,222,914        
Beginning balance, value at Mar. 31, 2021 $ 11,218 75,091,357 (23,552,903) (2,975,000) 48,574,672
Beginning balance, shares at Mar. 31, 2021 11,218,137        
Stock-based compensation 299,602 299,602
Stock issuance related to offering, net of offering costs of $4,596,257 (195,574) (195,574)
Stock issuance related to offering, net, of offering costs of $4,400,683 shares        
Common stock repurchased (499,270) (499,270)
Stock Options Exercised $ 5 32,390 32,395
Stock Option Exercised, shares 4,777        
Net income (loss) 1,257,444 1,257,444
Ending balance, value at Jun. 30, 2021 $ 11,223 $ 75,227,775 $ (22,295,459) $ (3,474,270) $ 49,469,269
Ending balance, shares at Jun. 30, 2021 11,222,914